Health Decisions Appoints Sheila Kiss as Head of European Clinical Operations

Health Decisions Appoints Sheila Kiss as Head of European Clinical Operations Health Decisions, Inc., the full-service clinical research organization (CRO) of choice for forward-looking biopharma and medical device companies and a leader in women’s health and diagnostics studies, has appointed Sheila Kiss as Head of European Clinical Operations. With more than 35 years’ experience in Clinical Operations and Project Management, Kiss will support Health Decisions’ dedicated Clinical Operations Team to execute research in Women’s Health and In Vitro Diagnostic clinical development. Read Full Release

US CRO Health Decisions and European CRO/SMO Comac Medical Expand Transatlantic Collaboration in Women’s Health Durham, North Carolina and Sofia, Bulgaria. Health Decisions, Inc., the leading US full-service women’s health specialty CRO and Comac Medical, a full-service CRO/SMO operating in 24 European countries, today announced an expansion of their strategic alliance to conduct women’s health clinical trials in the United States, Western and Central and Eastern Europe. “Health Decisions is pleased to strengthen its strategic women’s health alliance with our colleagues at Comac Medical,” stated Health Decisions’ Chief Executive Officer Patrick Phillips, BSc (Hons), D.Phil. “The Health Decisions/Comac Medical alliance provides sponsors of women’s health trials with extensive therapeutic and operational expertise and access to hundreds of investigational women’s health sites in the United States and Europe. These regions provide care for hundreds of millions of women and generate approximately two-thirds of the revenues of the global biopharmaceutical industry. This strategic alliance will enable Health Decisions to fulfill its mission of improving healthcare outcomes for women worldwide and assisting sponsors who share that goal.” Read Full Release